Your doctor may prescribe Tyzeka for the treatment of chronic hepatitis B disease. Hepatitis B is a viral infection of the liver. The disease is often chronic and can last for several years. Hepatitis B virus infects the liver and can cause liver damage over time. Tyzeka works by incorporating into the genetic material of the hepatitis B virus. By doing so, it prevents viral replication and helps to slow the infections. By slowing viral replication, it gives the immune system the chance to fight the infecftion. Fact Table Formula C10H14N2O5 License US FDA, EU EMA Bioavailability 68% Legal status Rx-only Chemical Name Telbivudine Elimination half-life 40 to 49 hours Dosage (Strength) 600mg Pregnancy No Known Risk Brands Tyzeka, Sebivo Protein binding Low PubChem CID 159269 MedlinePlus a607045 ChEBI 63624 ATC code J05AF11 DrugBank DB01265 KEGG D06675 Routes of administration By mouth

Tyzeka (Telbivudine)

The usual dosage for adults is 600 mg by mouth once daily. The dose may be adjusted for people with kidney problems.
The most common side effects of this medication include: Abdominal distension, Abdominal pain, Arthralgia, Back pain, Cough, Diarrhea, Dizziness, Dyspepsia, Exacerbation of hepatitis B, Fatigue, Fever, Headache, Hepatomegaly, Hyperbilirubinemia, Hypoesthesia, Increased amylase, Increased creatine phosphokinase, Increased serum ALT, Increased serum AST, Increased serum lipase, Insomnia, Lactic acidosis, Liver steatosis, Myalgia, Myopathy, Myositis, Nausea, Neutropenia, Paresthesia, Peripheral neuropathy, Pharyngolaryngeal pain, Pruritus, Rhabdomyolysis, Skin rash, Thrombocytopenia

Tyzeka (Telbivudine)

Directions

Ingredients

Cautions

Side Effects